These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 10395672
1. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5. Peijnenburg A, Van Eggermond MJ, Gobin SJ, Van den Berg R, Godthelp BC, Vossen JM, Van den Elsen PJ. J Immunol; 1999 Jul 15; 163(2):794-801. PubMed ID: 10395672 [Abstract] [Full Text] [Related]
2. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. Nagarajan UM, Peijnenburg A, Gobin SJ, Boss JM, van den elsen PJ. J Immunol; 2000 Apr 01; 164(7):3666-74. PubMed ID: 10725724 [Abstract] [Full Text] [Related]
3. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA. Bradley MB, Fernandez JM, Ungers G, Diaz-Barrientos T, Steimle V, Mach B, O'Reilly R, Lee JS. J Immunol; 1997 Aug 01; 159(3):1086-95. PubMed ID: 9233601 [Abstract] [Full Text] [Related]
4. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels. Schmetterer KG, Seidel MG, Körmöczi U, Rottal A, Schwarz K, Matthes-Martin S, Steinberger P, Pickl WF. Int Arch Allergy Immunol; 2010 Aug 01; 152(4):390-400. PubMed ID: 20197681 [Abstract] [Full Text] [Related]
5. Mutation in the class II trans-activator leading to a mild immunodeficiency. Wiszniewski W, Fondaneche MC, Le Deist F, Kanariou M, Selz F, Brousse N, Steimle V, Barbieri G, Alcaide-Loridan C, Charron D, Fischer A, Lisowska-Grospierre B. J Immunol; 2001 Aug 01; 167(3):1787-94. PubMed ID: 11466404 [Abstract] [Full Text] [Related]
6. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression. Peijnenburg A, Gobin SJ, van Eggermond MC, Godthelp BC, van Graafeiland N, van den Elsen PJ. J Immunol; 1997 Sep 15; 159(6):2720-7. PubMed ID: 9300692 [Abstract] [Full Text] [Related]
8. The bare lymphocyte syndrome and the regulation of MHC expression. Reith W, Mach B. Annu Rev Immunol; 2001 Sep 15; 19():331-73. PubMed ID: 11244040 [Abstract] [Full Text] [Related]
9. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor. Brickey WJ, Wright KL, Zhu XS, Ting JP. J Immunol; 1999 Dec 15; 163(12):6622-30. PubMed ID: 10586057 [Abstract] [Full Text] [Related]
11. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells. Liu A, Takahashi M, Toba K, Zheng Z, Hashimoto S, Nikkuni K, Furukawa T, Koike T, Aizawa Y. Hematol Oncol; 1999 Dec 15; 17(4):149-60. PubMed ID: 10725870 [Abstract] [Full Text] [Related]
12. Regulation of class II expression in monocytic cells after HIV-1 infection. Rakoff-Nahoum S, Chen H, Kraus T, George I, Oei E, Tyorkin M, Salik E, Beuria P, Sperber K. J Immunol; 2001 Aug 15; 167(4):2331-42. PubMed ID: 11490022 [Abstract] [Full Text] [Related]
13. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. Itoh-Lindstrom Y, Piskurich JF, Felix NJ, Wang Y, Brickey WJ, Platt JL, Koller BH, Ting JP. J Immunol; 1999 Sep 01; 163(5):2425-31. PubMed ID: 10452977 [Abstract] [Full Text] [Related]
14. Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene. Peijnenburg A, Van Eggermond MC, Van den Berg R, Sanal O, Vossen JM, Van den Elsen PJ. Immunogenetics; 1999 Apr 01; 49(4):338-45. PubMed ID: 10079298 [Abstract] [Full Text] [Related]
15. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Steimle V, Otten LA, Zufferey M, Mach B. Cell; 1993 Oct 08; 75(1):135-46. PubMed ID: 8402893 [Abstract] [Full Text] [Related]
16. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression. Long AB, Ferguson AM, Majumder P, Nagarajan UM, Boss JM. Mol Immunol; 2006 Feb 08; 43(5):395-409. PubMed ID: 16337482 [Abstract] [Full Text] [Related]
17. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. Villard J, Lisowska-Grospierre B, van den Elsen P, Fischer A, Reith W, Mach B. N Engl J Med; 1997 Sep 11; 337(11):748-53. PubMed ID: 9287230 [Abstract] [Full Text] [Related]
18. Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA. Quan V, Towey M, Sacks S, Kelly AP. Immunogenetics; 1999 Oct 11; 49(11-12):957-63. PubMed ID: 10501838 [Abstract] [Full Text] [Related]
19. Regulation of MHC class II genes: lessons from a disease. Mach B, Steimle V, Martinez-Soria E, Reith W. Annu Rev Immunol; 1996 Oct 11; 14():301-31. PubMed ID: 8717517 [Abstract] [Full Text] [Related]
20. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. Butticè G, Miller J, Wang L, Smith BD. Circ Res; 2006 Mar 03; 98(4):472-9. PubMed ID: 16439692 [Abstract] [Full Text] [Related] Page: [Next] [New Search]